Abstract
The aim of this study was to develop a delivery system to enable the promotion of the antitumor potential of fucoidan (FUC). FUC/N-trimethylchitosan (TMC) ion-complex submicron particles (FUC/TMC-SMP) were produced by ionic complexation, and their particle characteristics were investigated. Antitumor effect was examined in vivo using sarcoma 180-bearing mice by oral administration, and body weight loss was checked as an index of toxic side effects. FUC/TMC-SMP could be obtained by the complexation of negatively charged fucoidan with positively charged N-trimethylchitosan under aqueous conditions. The mean particle size was 325 nm and mean FUC content was 47 % (w/w). Oral administration was conducted using two treatment schedules, that is, pre- and post-tumor inoculation. As to pre-treatment, oral administration was performed from 13 days before inoculation to 1 day before inoculation every other day. For post-treatment, preparation samples were administered orally from 1 day after inoculation to 13 days after inoculation every other day. FUC/TMC-SMP were more effective than FUC solution and suppressed tumor growth significantly in both treatment schedules. FUC/TMC-SMP are suggested to be a useful oral delivery system enhancing the antitumor potential of FUC.
Keywords: Ion-complex submicron particles, fucoidan, N-trimethylchitosan, antitumor effect, oral administration, treatment schedule, Submicron particles, Ionic complexation, Particle characteristics, Pre-treatment, Post-treatment, Sarcoma 180, Toxic side effect
Current Nanoscience
Title: Preparation and Antitumor Effect of N-Trimethylchitosan/Fucoidan Ion-Complex Submicron Particles
Volume: 7 Issue: 4
Author(s): Kazuya Hayashi, Masanaho Sasatsu, Yoshiharu Machida and Hiraku Onishi
Affiliation:
Keywords: Ion-complex submicron particles, fucoidan, N-trimethylchitosan, antitumor effect, oral administration, treatment schedule, Submicron particles, Ionic complexation, Particle characteristics, Pre-treatment, Post-treatment, Sarcoma 180, Toxic side effect
Abstract: The aim of this study was to develop a delivery system to enable the promotion of the antitumor potential of fucoidan (FUC). FUC/N-trimethylchitosan (TMC) ion-complex submicron particles (FUC/TMC-SMP) were produced by ionic complexation, and their particle characteristics were investigated. Antitumor effect was examined in vivo using sarcoma 180-bearing mice by oral administration, and body weight loss was checked as an index of toxic side effects. FUC/TMC-SMP could be obtained by the complexation of negatively charged fucoidan with positively charged N-trimethylchitosan under aqueous conditions. The mean particle size was 325 nm and mean FUC content was 47 % (w/w). Oral administration was conducted using two treatment schedules, that is, pre- and post-tumor inoculation. As to pre-treatment, oral administration was performed from 13 days before inoculation to 1 day before inoculation every other day. For post-treatment, preparation samples were administered orally from 1 day after inoculation to 13 days after inoculation every other day. FUC/TMC-SMP were more effective than FUC solution and suppressed tumor growth significantly in both treatment schedules. FUC/TMC-SMP are suggested to be a useful oral delivery system enhancing the antitumor potential of FUC.
Export Options
About this article
Cite this article as:
Hayashi Kazuya, Sasatsu Masanaho, Machida Yoshiharu and Onishi Hiraku, Preparation and Antitumor Effect of N-Trimethylchitosan/Fucoidan Ion-Complex Submicron Particles, Current Nanoscience 2011; 7 (4) . https://dx.doi.org/10.2174/157341311796196862
DOI https://dx.doi.org/10.2174/157341311796196862 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Role of nanomaterials in fabrication of coatings, Machining and Joining
The application of nanoscience has brought about a revolution in the field of mechanical engineering by providing novel materials, boosting manufacturing processes, and generating cutting-edge products. The purpose of this special issue is to investigate the enormous impact that nanoscience has had on mechanical engineering, with a particular emphasis on ...read more
Advanced Inorganic Nanocomposites and Their Emerging Applications
This special issue collection will highlight developments on the recent trends about the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc. and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis and their characterizations, ...read more
Applicability of Nanotechnology for Performance Enhancement of Clean Energy Technologies
Population growth, industrialization, and improvement in living quality would lead to further increase in energy demand in near future. Regarding the disadvantages of fossil fuels such as fluctuations in their price, high emissions of greenhouse gases and restriction of their sources, it is crucial to use and exploit alternative energy ...read more
Graphene and 2D Materials for Energy Storage and Conversion
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Osteoblast Differentiation and Control by Vitamin D and Vitamin D Metabolites
Current Pharmaceutical Design Antisense Technologies Targeting Fatty Acid Synthetic Enzymes
Recent Patents on Anti-Cancer Drug Discovery Lipid Based Anti-Retroviral Nanocarriers: A Review of Current Literature and Ongoing Studies
Drug Delivery Letters The Therapeutic Potential of Adenosine Triphosphate as an Immune Modulator in the Treatment of HIV/AIDS: A Combination Approach with HAART
Current HIV Research 3-Substituted Isocoumarins as Thymidine Phosphorylase Inhibitors
Letters in Drug Design & Discovery CD93 and Related Family Members: Their Role in Innate Immunity
Current Drug Targets Tumor Angiogenesis and VEGFR-2: Mechanism, Pathways and Current Biological Therapeutic Interventions
Current Drug Metabolism MicroRNAs in Human Diseases
Recent Patents on DNA & Gene Sequences Mechanism of Action of Flavonoids in Prevention of Inflammation- Associated Skin Cancer
Current Medicinal Chemistry C-Myc Signaling Pathway in Treatment and Prevention of Brain Tumors
Current Cancer Drug Targets The Drug Targeting and Delivery Approach Applied to Pt-Antitumour Complexes. A Coordination Point of View
Current Medicinal Chemistry Glucans as Biological Response Modifiers
Endocrine, Metabolic & Immune Disorders - Drug Targets Angiogenesis and Angiogenesis Inhibitors: a New Potential Anticancer Therapeutic Strategy
Current Drug Targets - Immune, Endocrine & Metabolic Disorders The Involvement of Heat Shock Proteins and Related Molecules in the Resistance to Therapies in Breast and Gynecologic Cancer
Current Cancer Therapy Reviews Insect Larvae: A New Platform to Produce Commercial Recombinant Proteins
Current Pharmaceutical Biotechnology Helicase Domain Containing Proteins in Human Disorders
Current Genomics Genetic Alterations in Differentiated Thyroid Cancers
Endocrine, Metabolic & Immune Disorders - Drug Targets Bcl-2 Proteins: Targets and Tools for Chemosensitisation of Tumor Cells
Current Medicinal Chemistry - Anti-Cancer Agents Immunotherapy: A Potential Approach to Targeting Cancer Stem Cells
Current Cancer Drug Targets A Systematic Analysis of Physicochemical and ADME Properties of All Small Molecule Kinase Inhibitors Approved by US FDA from January 2001 to October 2015
Current Medicinal Chemistry